Your browser doesn't support javascript.
loading
The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment on gingival crevicular fluid levels of transforming growth factor-beta 1, tissue plasminogen activator and plasminogen activator inhibitor 1 in smoking and non-smoking chronic periodontitis patients: A split-mouth, randomized control study.
Pamuk, F; Lütfioglu, M; Aydogdu, A; Koyuncuoglu, C Z; Cifcibasi, E; Badur, O S.
Afiliação
  • Pamuk F; Department of Periodontology, Faculty of Dentistry, Yeditepe Univesity, Istanbul, Turkey.
  • Lütfioglu M; Department of Periodontology, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey.
  • Aydogdu A; Department of Periodontology, Faculty of Dentistry, Ondokuzmayis University, Samsun, Turkey.
  • Koyuncuoglu CZ; Department of Periodontology, Faculty of Dentistry, Istanbul Research and Application Center, Baskent University, Istanbul, Turkey.
  • Cifcibasi E; Department of Periodontology, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey.
  • Badur OS; Department of Periodontology, Faculty of Dentistry, Istanbul University, Istanbul, Turkey.
J Periodontal Res ; 52(5): 872-882, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28394081
ABSTRACT
BACKGROUND AND

OBJECTIVE:

This study aimed to investigate the effects of low-level laser therapy (LLLT) as an adjunct to scaling and root planing (SRP) on smoking and non-smoking patients with chronic periodontitis. MATERIAL AND

METHODS:

The study was conducted using a split-mouth design with 30 patients with chronic periodontitis (15 smokers, 15 non-smokers) and 30 healthy individuals matched for age, sex and smoking status as controls. Groups were constituted as follows Cp+SRP+Sham non-smokers with chronic periodontitis treated with SRP; Cp+SRP+LLLT non-smokers with chronic periodontitis treated with SRP+LLLT; SCp+SRP+Sham smokers with chronic periodontitis treated with SRP; SCp+SRP+LLLT smokers with chronic periodontitis treated with SRP+LLLT; C control group comprised of periodontally healthy non-smokers; SC control group comprised of periodontally healthy smokers. LLLT was first applied on the same day as SRP and again on days 2 and 7 after SRP treatment. Clinical parameters were recorded before non-surgical periodontal treatment (baseline) and on day 30. Gingival crevicular fluid samples were collected before periodontal treatment (baseline) and during follow-up visits on days 7, 14 and 30. Gingival crevicular fluid transforming growth factor (TGF)-ß1, tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) levels were measured using enzyme-linked immunosorbent assay.

RESULTS:

All clinical parameters showed significant reductions between baseline and day 30 following SRP treatment in both the LLLT and sham groups (P<.001). No significant differences were observed between the LLLT and sham groups of either the smokers or non-smokers (P>.05). Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+SRP+sham and SCp+SRP+LLLT groups (P<.05), and gingival crevicular fluid tPA levels decreased significantly in the Cp+SRP+sham, Cp+SRP+LLLT and SCp+SRP+LLLT groups (P<.05). Gingival crevicular fluid TGF-ß1 levels decreased significantly in all treatment groups (P<.05). Although no significant differences were found between the gingival crevicular fluid PAI-1, tPA and TGF-ß1 levels of the LLLT versus sham groups (P>.05) at any of the time points measured, both LLLT groups showed significant reductions in tPA/PAI-1 ratios over time.

CONCLUSION:

Within the limits of this study, LLLT may be understood to play a role in the modulation of periodontal tissue tPA and PAI-1 gingival crevicular fluid levels, particularly in smoking patients with chronic periodontitis, and may thus be recommended as an adjunct to non-surgical periodontal treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Líquido do Sulco Gengival / Ativador de Plasminogênio Tecidual / Inibidor 1 de Ativador de Plasminogênio / Terapia com Luz de Baixa Intensidade / Fator de Crescimento Transformador beta1 / Terapia a Laser / Periodontite Crônica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Periodontal Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Líquido do Sulco Gengival / Ativador de Plasminogênio Tecidual / Inibidor 1 de Ativador de Plasminogênio / Terapia com Luz de Baixa Intensidade / Fator de Crescimento Transformador beta1 / Terapia a Laser / Periodontite Crônica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Periodontal Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Turquia